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Background: Breast cancer is a leading type of cancer affecting women around the world. Its 
incidence is increasing in developed and developing countries. Breast cancer is the leading cause of 
death among women in Indonesia with 19,731 cases of death in 2014. In addition to mortality, 
breast cancer causes psychosocial effect in the affected and the family. This study aimed to 
determine the risk factors of breast cancer in women at Dr. Moewardi Hospital, Surakarta, Central 
Java. 
Subjects and Method: This was an analytical observational study with case control design. The 
study was conducted at Dr. Moewardi Hospital, Surakarta, from October to December, 2017. A 
total sample of 200 study subjects consisting of 100 women with breast cancer and 100 women 
without breast cancer were selected for this study by fixed disease sampling. The dependent 
variable was breast cancer. The independent variables were age at menarche, age at first 
pregnancy, parity, duration of breastfeeding, use of fertility hormone, duration of hormonal 
contraceptive use, and age at menopause. The data was collected  by questionnaire and analyzed by 
multiple logistic regression. 
Results: The risk of breast cancer increased with earlier age at menarche <12 years old (OR= 2.71; 
95% CI= 1.06 to 6.96; p= 0.037), delayed age at first pregnancy ≥30 years old (OR=3.01; 95% CI= 
1.16 to 7.78; p= 0.023), delayed age at menopause ≥55 years old (OR=1.07; 95% CI=0.82 to 6.30; 
p= 0.001), longer hormonal contraceptive use ≥10 years (OR=3.25; 95% CI= 1.20 to 9.63 p= 
0.003). 
Conclusion: The risk of breast cancer increases with earlier age at menarche, delayed age at first 
pregnancy, delayed age at menopause, longer hormonal contraceptive use. 
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BACKGROUND 
Current disease patterns are shifting from 
infectious diseases and nutritional pro-
blems to degenerative diseases including 
breast cancer (In Sibio et al., 2016).  
Breast cancer affects many women in 
the world. Breast cancer is characterized by 
uncontrolled or malignant growth of breast 
epithelial tissues (Lukong, 2017). Its inci-
dence increases in developed and deve-
loping countries. Breast cancer accounts for 
29% of all new cancers and 14% of all 
cancer deaths in women worldwide in 2012. 
There were reported 1.7 million new cases 
of breast cancer with 522,000 deaths in 
2012 (Leon et al., 2017). The incidence of 
breast cancer in developed countries in 
2012 was as many as 793,700 cases. The 
incidence rate of breast cancer is higher 
than colon, rectum, lung, bronchial, and 
tracheal cancers (World Health Orga-
nization, 2014; Ministry of Health RI 
Center for Health Data and Information, 
2015; Kweon et al., 2017).  
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In developed countries, the number of 
deaths from breast cancer amounted to 
197,600 deaths. This breast cancer specific 
death rate was lower than that in the 
developing countries. For example, in the 
United States by 2015 there were 231,840 
new cases and 40,290 deaths due to breast 
cancer (Di Sibio et al., 2016). 
In Southeast Asia, the incidence rate 
of breast cancer was 27% of all cancers in 
women. Breast cancer mortality rate was 
18% of all deaths from breast cancer 
(Graham et al., 2016). 
In Indonesia, the incidence of breast 
cancer was 48,998 cases with 19,731 deaths 
(Ministry of Health RI Center for Data and 
Health Information, 2015). In 2013, the 
highest prevalence of breast cancer 
occurred in Yogyakarta Province, which 
was 4.1%. This figure was higher than the 
national rate of 1.4%. The highest 
prevalence of breast cancer occurred in 
Central Java and Bali, ie 2.1% and 2.0% 
(Ministry of Health RI Center for Data and 
Information Health, 2016). 
To the extent of the author’s 
knowledge, studies on the risk factors of 
breast cancer using multiple regression 
analysis in Indonesia are sparse. Based on 
the background, the author were interested 
to examine the risk factors of breast cancer 
in women at Dr. Moewardi Hospital, 
Surakarta. 
 
SUBJECTS AND METHOD 
1. Study design 
This was an analytic observational study 
with a case control design. The study was 
conducted at Mawar III ward, Dr. 
Moewardi Hospital, Surakarta, Central 
Java, Indonesia, from October to December 
2017. 
2. Population and sample 
A sample of 200 study subjects was selected 
for this study by fixed disease sampling, 
consisting of 100 breast cancer patients and 
100 non breast cancer in-patients in Mawar 
ward, Dr. Moewardi hospital, Surakarta 
with 1:1 ratio.  
The exclusion criteria were in-
patients who had complication disease or 
had psychiatric disorder, unable to read or 
write.  
3. Study variables 
The dependent variable was breast cancer. 
The independent variables were age at 
menarche, age at first pregnancy, parity, 
duration of breastfeeding, use of fertility 
hormone, duration of hormonal contra-
ceptive use, and age at menopause. 
4. Operational definition of variables 
Breast cancer was defined as an abnormal 
growth of abnormal breast tissue with 
excessive growth, no coordination with 
normal tissue growth, grows infiltratively 
and destructively, and may metastasize and 
will continue to grow. The data of breast 
cancer cases and non breast cancer control 
were taken from the medical record. The 
measurement scale was categorical, coded 
0 for non breast cancer and 1 for breast 
cancer. 
Age at menarche was defined as the 
maternal age (year) at the first menstrual 
cycle. The data were collected by 
questionnaire. The measurement scale was 
continuous, but for the purpose of analysis 
transform into dichotomous, coded 0 for 
≥12 years old and 1 for <12 years old. 
Age at first pregnancy was defined as 
maternal age (year) at the first pregnancy. 
The data were collected by questionnaire. 
The measurement scale was continuous, 
but for the purpose of analysis transform 
into dichotomous, coded 0 for <30 years 
old and 1 for ≥30 years old. 
Parity was defined as the number of 
children who had been born. The data were 
collected by questionnaire. The measure-
ment scale was continuous. 
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Birth spacing was defined as the time 
interval (year) from previous child birth 
until the current pregnancy. The data were 
collected by questionnaire. The measure-
ment scale was continuous. 
Length of contraceptive use was 
defined as the duration (year) of delaying or 
regulating the number of pregnancies using 
artificial hormones. The data were collected 
by questionnaire. The measurement scale 
was continuous, but for the purpose of 
analysis transform into dichotomous, coded 
0 for <10 years and 1 for ≥10 years. 
5. Data analysis 
The sample characteristics were described 
in frequency, mean, standard deviation, 
minimum, and maximum, for continuous 
data. The sample characteristics were 
described in frequency and percent, for 
categorical data. The bivariate analysis 
involving categorical data was run by cross 
tabulation with odds ratio as the measure of 
the association and Chi square as the 
statistical test. The multivariate analysis 
employed a multiple logistic regression.  
6. Research Ethics 
The research ethical clearance was granted 
from the Research Ethics Committee at Dr. 
Moewardi Hospital, Surakarta, Central 
Java, Indonesia. Research ethics included 
issues such as informed consent, anony-
mity, confidentiality, and ethical clearance. 
 
RESULTS 
1. Univariate analysis 
Table 1 shows the descriptive characteris-
tics of the sample consisting of 200 study 
subjects. Most of the study subjects aged 
50-59 years (36.5%). As many as 62.0% 
study subjects attained <Senior high 
school. A few subjects were diploma or 
graduate (15.5%). One-third of the study 
subjects were housewives. Half of the study 
subjects had income <Rp 1,000,000. 
Table 1. Sample characteristics of maternal age, education, and employment 
Characteristics n Percent (%) 
Age group   
20-29 years 2 1.0 
30-39 years 20 10.0 
40-49 years 64 32.0 
50-59 years 73 36.5 
60-69 years 32 16.0 
70-79 years  9 4.5 
Education level   
Elementary school and junior high 
school 
124 62.0 
Senior high school 45 22.5 
Diploma or bachelor degree 31 15.5 
Employment    
Farmer  18 9.0 
Laborer  42 21.0 
Working at house 60 30.0 
Civil servant 14 14.0 
Merchant 14 7.0 
Private employee 13 13.0 
Employee  39 19.5 
Income   
<Rp 1,000,000 104 52.0 
Rp 1,000,000 to <Rp 2,000,000 42 21.0 
Rp 2,000,001  to <Rp 3,000,000 25 12.5 
Rp 3,000,001 to <Rp 4,000,000 18 9.0 
≥ Rp 4,000,000 11 5.5 
Listyawardhani et al./ Risk Factors of Breast Cancer in Women at Dr. Moewardi 
e-ISSN: 2549-0273 (online)  121 
2. Bivariate analysis 
Table 2 shows the results of bivariate 
analysis between breast cancer and age at 
menarche, age at menopause, parity, and 
duration of contraceptive use. As expected 
the results of these crude analyses suggest 
associations between breast cancer and age 
at menarche, age at menopause, parity, and 
duration of contraceptive use. For example, 
women with age at menarche ≥12 years 
were 0.38 times less likely to have breast 
cancer than women with age at menarche 
<12 years. Similarly, women with hormonal 
contraceptive use ≥10 years were 3.60 
times more likely to have breast cancer 
than women with <10 years. 
 
Table 2. Chi-Square test on the association between breast cancer and the age at 
menarche, the age at menopause, parity, and duration of contraceptive use 
Independent Variable 
Case Control 
OR 95% CI  p 
n % n % 
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Table 3. A multiple logistic regression analysis on the risk factors of breast cancer 
in women 
Independent variables OR 95% CI p 
Age at menarche <12 years 2.71 1.06 to 6.96 0.037 
Age at first pregnancy ≥30 years 3.01 1.16 to 7.78 0.023 
Age at menopause <55 years 1.07 0.82 to 6.30 0.001 
Hormonal contraceptive use ≥10 years 3.25 1.20 to 9.63 0.003 
N Observed = 200 
-2 Log likelihood = 86.70 
Nagelkerke R Square = 81.4% 
   
 
3. Multivariate analysis 
Table 3 shows the results of multiple 
logistic regression analysis on the risk 
factors of breast cancer in women. As 
expected, age at menarche was a moderate 
risk factor of breast cancer. Women with 
age at menarche <12 years were more likely 
to get breast cancer than age at menarche 
≥12 years (OR= 2.71; 95% CI= 1.06 to 6.96; 
p= 0.037).  
Age at first pregnancy was a strong 
risk factor of breast cancer. Women with 
age at first pregnancy ≥30 years were more 
likely to get breast cancer than age at 
menarche <30 years (OR= 3.01; 95% CI= 
1.16 to 7.78; p= 0.023). 
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Age at menopause <55 years was a 
weak risk factor of breast cancer. Women 
with age at menopause <55 years were 
more likely to get breast cancer than age at 
menopause ≥55 years (OR= 1.07; 95% CI= 
0.82 to 6.30; p= 0.001). 
Hormonal contraceptive use of ≥10 
years was a strong risk factor of breast 
cancer. Women with hormonal contra-
ceptive use ≥10 years were more likely to 
get breast cancer than women with 
hormonal contraceptive use <10 years 




From the multiple regression analysis of 
the present study, it was indicated that all 
of the dependent variables investigated in 
this study i.e. age at menarche, age at 
menopause, age at first pregnancy, and use 
of hormonal contraceptive, were associated 
with the risk of breast cancer. 
1. The association between age at 
menarche and breast cancer 
Menarche marks the onset of ovarian 
activity associated with reproduction, and 
affect breast cancer risk. During women's 
reproductive years (broadly the time 
between menarche and menopause) the 
ovary produces steroid hormones that 
directly affect development and function of 
the breast. Early menarche and late 
menopause are known to increase women's 
risk of developing breast cancer 
(Collaborative Group on Hormonal Factors 
in Breast Cancer, 2012). 
The present study found that age at 
menarche had a significant relationship 
with breast cancer in women. The result of 
the multivariate analysis shows that age at 
menarche <12 years increased the risk of 
breast cancer (OR = 2.71; 95% CI = 1.06 to 
6.96; p = 0.037).  
This result is consistent with Li et al., 
(2017) which stated that age at menarche 
had a significant relationship with the 
incidence of breast cancer. 
This study is also consistent with a 
meta-analysis, which reported that breast 
cancer risk increased by a factor of 1.05 
(95% CI= 1.04–1.06; p<0.001) for every 
year younger at menarche (Collaborative 
Group on Hormonal Factors in Breast 
Cancer, 2012).  
Too early menarche, which is less 
than 12 years, causes early exposure to 
estrogen hormone. In turn, the increased 
estrogen hormone causes the abnormal 
growth of cells. Breast cancer can occur due 
to estrogen stimulation of epithelial cell 
division. Estrogen with its metabolites 
directly acts as a mutagen, which results in 
the emergence of cancer cells (Hamajima et 
al., 2012).  
Conversely, the estrogen hormone 
prevents heart attack and protects bones. 
Insufficient estrogen hormone at a young 
age increases a woman's risk for heart or 
bone disorders (Ewaid and Al-Azzawi, 
2016). 
This result is consistent with Ewaid 
and Al-Azzawi studies (2016) which 
reported that early menstrual period <12 
years were associated with an increased 
risk of breast cancer. Conversely, age 
menarche ≥17 years were associated with a 
decreased risk of breast cancer by 30%. 
2. The association between age at 
first pregnancy and the risk of 
breast cancer  
This study found that age at first pregnancy 
was a strong risk factor of breast cancer. 
Women with age at first pregnancy ≥30 
years were more likely to get breast cancer 
than age at menarche <30 years.  
The fact that reproductive factors 
have significant influence on the risk of 
breast cancer is well known. Early age of 
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first full-term birth is highly protective 
against late-onset breast cancers, but each 
pregnancy, including the first one, 
increases the risk of early-onset breast 
cancer (Kobayashi et al., 2012). 
This is possible because at the first-
trimester pregnancy the estrogen hormone 
level is high, resulting in the process of cell 
multiplication through rapid mitosis that 
causes cancer cell division (Becker, 2015; 
Goldberg et al., 2015; Morales et al., 2013). 
This study is consistent with the study 
of Mockus et al. (2015) which states that 
the increased risk for breast cancer is 
associated with increased age at first 
pregnancy. 
Delay of first birth together with low 
parity and short duration of breast feeding 
are increasing social trends in developed 
countries. Therefore, breast cancer risk as a 
result of reproductive factors will not 
decrease in these countries in the 
foreseeable future (Kobayashi et al., 2012). 
3. The association between age at 
menopause and the risk of breast 
cancer  
Menopause marks the cessation of ovarian 
activity associated with reproduction, and 
affect breast cancer risk (Collaborative 
Group on Hormonal Factors in Breast 
Cancer, 2012). 
The present study found that age at 
menopause <55 years was a weak risk 
factor of breast cancer. Women with age at 
menopause <55 years were more likely to 
get breast cancer than age at menopause 
≥55 years. 
Women who experience menopause 
at older ages have longer exposure of 
estrogen hormone in the blood, which will 
result in an increased risk of breast cancer 
(Bakht and Najafi, 2010; Mahmoud et al., 
2015; Nagrani et al., 2016). 
The period between first menstrual 
occurrence and age at first pregnancy is a 
window of initiation of breast cancer 
development. Anatomically and function-
ally, the breasts will experience atrophy 
according to age. Less than 25% of breast 
cancers occur prior to menopause (Becker, 
2015, Morales et al., 2013). Women with 
menopause at age 55 or older have a 50% 
higher risk of breast cancer than less than 
55 years. Similarly, women with menopause 
less than 45 years have a 30% higher risk of 
breast cancer than over 45 years (Mockus et 
al., 2015). 
The main risk of breast cancer is the 
increasing age of the individual. The longer 
a person lives, the higher the risk of cancer 
because of the physical condition decreases 
and easily becomes abnormal (Laamiri et 
al., 2015; Mahmoud et al., 2015; Nagrani et 
al., 2016). 
As discussed above, prior studies 
indicate that women with menopausal 
symptoms have lower estrogen levels 
because they go through menopause as 
compared with women who do not 
experience them. Given the central role of 
hormones in the etiology of breast cancer, a 
link between menopausal symptoms and 
breast cancer is plausible.  
Huang et al. (2011) went further to 
evaluate the association between meno-
pausal symptoms and breast cancer risk. 
The authors found that women who ever 
experienced menopausal symptoms had 
lower risks of invasive ductal carcinoma 
(IDC) (OR = 0.5; 95% CI: 0.3-0.7), invasive 
lobular carcinoma (ILC) (OR = 0.5; 95% CI: 
0.3-0.8), and invasive ductal-lobular 
carcinoma (IDLC) (OR = 0.7; 95% CI: 0.4-
1.2). These reductions in risk were 
independent of recency and timing of 
hormone therapy use, age at menopause, 
and body mass index. Increasing intensity 
of hot flushes among women who ever 
experienced hot flushes was also associated 
with decreasing risks of all three breast 
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cancer subtypes (P values for trend all ≤ 
0.017). Huang et al. (2011) concludes that 
women who ever experienced menopausal 
symptoms have a substantially reduced risk 
of breast cancer, and that severity of hot 
flushes is also inversely associated with 
risk. 
4. The association between use of 
contraceptive and the risk of 
breast cancer  
This study found that the longer using 
hormonal contraceptives will provide 
increased risk of breast cancer. Women 
who use hormonal contraceptives <10 years 
are at lower risk than women who never use 
hormonal contraceptives. 
The result of the present study is 
consistent with a prospective cohort study 
by Kumle et al. (2002), which was 
specifically designed to examine the role of 
hormonal contraceptives in relation to 
breast cancer was conducted in Norway and 
Sweden. This study was entitled Women’s 
Lifestyle and Health. Of 196,000 invited 
women aged 30–49 years, 106,844 women 
answered a 4-page questionnaire. Alto-
gether, 103,027 women providing infor-
mation on contraceptive use were included 
in the analysis, and 1,008 primary invasive 
breast cancers were diagnosed throughout 
1999 (end of follow-up). The author used 
proportional hazard regression model to 
calculate relative risks (RRs) with 
adjustment for age and other possible 
confounders. An increased breast cancer 
risk was observed among women who were 
recent users of oral contraceptives (OCs) of 
any type at the start of follow-up (RR= 1.6; 
95% CI= 1.2–2.1). 
The loss of the cellular function of the 
programmed cell (apoptosis) will lead to 
the inability to detect the presence or 
absence of cell damage resulting from 
damage to DNA, so that abnormal cells will 
continue to be uncontrollably polymerized 
(Mahmoud et al., 2015; Nakamura et al. , 
2017). 
The result of this study is consistent 
with the study conducted by Youlden et al. 
(2014), which stated that there was a 
significant relationship between the 
hormonal contraceptives use and the risk of 
breast cancer. 
Devi (2011) stated that women who 
consumed combined contraceptive pill had 
a risk of 1.86 times for breast cancer than 
those with the non-combined contraceptive 
method. The duration of combined 
contraceptive method use in the case group 
was highest in the 5-9 year of age group 
(Oktaviana, 2011). 
Li et al. (2017b) conducted a meta-
analysis to investigate the association 
between oral contraceptive use as a risk 
factor and triple-negative breast cancer. 
The study indicated that women who used 
OCs had a greater risk of TNBC compared 
with women who did not. This conclusion 
prompts that women who used OCs should 
be examined more closely in population 
screenings of breast cancer, as they may 
benefit from prevention and early detection 
strategies. 
The association between oral 
contraceptive use and risk of breast cancer 
was also evident by histologic type of the 
breast cancer. Newcomer et al. (2003) 
examined the association between oral 
contraceptive use and risk of specific breast 
cancer histopathologies in a large, multi-
center, population-based, case-control 
study. Women younger than age 75 with a 
new diagnosis of invasive breast cancer 
were identified from 4 statewide tumor 
registries. The authors compared women 
with lobular (n= 493) and ductal carcinoma 
(n= 5,510) to randomly selected controls 
(n= 9,311). Odds ratios (OR) and 95% 
confidence intervals (CI) for each histologic 
type were estimated using polytomous 
Listyawardhani et al./ Risk Factors of Breast Cancer in Women at Dr. Moewardi 
e-ISSN: 2549-0273 (online)  125 
logistic regression, adjusted for other breast 
cancer risk factors. Current oral contra-
ceptive use was associated with increased 
risk of lobular carcinoma (OR= 2.6, 95% 
CI= 1.0 to 7.1) and there was a significant 
trend (p= 0.017) of increased risk with 
more recent use. Oral contraceptive use was 
not clearly associated with ductal 
carcinoma (OR= 1.2, 95% CI= 0.8 to 1.9). 
These results suggest that the association 
between oral contraceptive use and risk of 
breast cancer may vary by histologic type. 
The present study concludes that the 
risk of breast cancer increases with earlier 
age at menarche, delayed age at first 
pregnancy, delayed age at menopause, and 
longer hormonal contraceptive use. 
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